CONMED
CNMD
290 hedge funds and large institutions have $2.44B invested in CONMED in 2024 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 96 increasing their positions, 110 reducing their positions, and 39 closing their positions.
412% more call options, than puts
Call options by funds: $9.13M | Put options by funds: $1.78M
3% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 39
0% more funds holding
Funds holding: 290 → 290 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less capital invested
Capital invested by funds: $2.47B → $2.44B (-$32.5M)
5.8% less ownership
Funds ownership: 115.87% → 110.07% (-5.8%)
13% less repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 110
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$7.83M |
| 2 |
OCM
Osterweis Capital Management
San Francisco,
California
|
+$6.81M |
| 3 |
CIM
Confluence Investment Management
St. Louis,
Missouri
|
+$6.78M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$5.78M |
| 5 |
Renaissance Technologies
New York
|
+$5.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$30.2M |
| 2 |
BNP Paribas Asset Management
Paris,
France
|
-$22.2M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$22M |
| 4 |
Man Group
London,
United Kingdom
|
-$16.1M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$15.8M |
CNMD Hedge Fund Activity: Q3 2024 in Review
290 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q3 2024, worth a combined $2.44B — down 1.3% from $2.47B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new CNMD positions and 39 closed out — a net gain of 1 holder — while 96 added to existing stakes and 110 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $7.83M. The largest seller was Millennium Management, cutting an estimated $30.2M.
- 290 institutional investors held CONMED (CNMD) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $2.44B of CONMED stock for Q3 2024, down 1.3% quarter-over-quarter.
- 40 funds opened new CONMED positions in Q3 2024 and 39 closed out, a net change of +1 holder.
- The largest CONMED buyer in Q3 2024 was JP Morgan Chase, an estimated $7.83M added.
- The largest CONMED seller in Q3 2024 was Millennium Management, an estimated $30.2M sold.
Based on aggregated 13F filings for Q3 2024.